Pharmacy Insights Podcast

Introducing the Pharmacy Insights Podcast from Optum Rx. This ongoing series features our most experienced leaders examining the topics currently challenging pharmacy benefit plan sponsors. Join Optum Rx Senior Vice President of Clinical Consulting Scott Draeger as he interviews leading experts to uncover the emerging solutions needed to control rising prescription drug costs and ensure the best possible quality of care.

Episodes

The Year Ahead in Pharmacy: What to Expect and What's to Come

February 13, 2024 • 33 mins

Host Scott Draeger welcomes Optum Rx Vice President of Trend Insights & Analytics Michelle Kamprath and Optum Rx Senior Director of Drug Pipeline & Surveillance Bill Dreitlein for a lively discussion of the year ahead in pharmacy. Find out which trends are expected to make noise in 2024 including the ongoing obesity drug dilemma facing plan sponsors, the impact of the profusion of biosimilars on drug costs, and some noteworthy drug...

Mark as Played

Preparing For the Gene Therapy Era

November 7, 2023 • 22 mins

Gene therapies represent a true revolution in the way certain genetic diseases are treated. They are also the most expensive drugs in history. In this episode, Optum Rx Senior Vice President of Clinical Consulting Scott Draeger welcomes Nick Cashman, Specialty Clinical Consultant for Optum Rx, and Arash Sadeghi, Clinical Pharmacist, Pipeline & Drug Surveillance at Optum Rx. They dive in on the science of gene therapies and discus...

Mark as Played

Making the Invisible Visible: Why Health Equity Matters

October 4, 2023 • 27 mins

Affording everyone a fair and just opportunity to attain their highest level of health is an ongoing challenge. To better understand the issue, Optum Rx Senior Vice President of Clinical Consulting Scott Draeger welcomed Dr. Sumit Dutta, Chief Medical Officer for OptumRx, and Corey Coleman, Vice President of OptumRx Health Equity and Strategic Partnerships for a recent episode of the Pharmacy Insights Podcast. Together they discu...

Mark as Played

The biosimilar wave has arrived. Now what?

July 26, 2023 • 28 mins

Biosimilar options have long been sought as a counterweight to expensive, branded biologic medicines. Now a wave of biosimilar options to the drug Humira® are entering the market. Hear Savitha Vivian, Optum Rx Senior Vice President, Formulary Management and Strategy, and Jamey Millar, Optum Rx Senior Vice President, Industry Relations, discuss how providers of pharmacy benefits can take advantage of biosimilars to reduce prescripti...

Mark as Played

How Choice and Transparency are Changing the PBM Industry

May 31, 2023 • 18 mins

As increasingly expensive medications continue to enter the market and questions about prescription drug affordability become everyday topics of conversation, the pharmacy benefit management space is undergoing profound changes. To get a sense of the forces driving these changes, Optum Rx Senior Vice President of Clinical Consulting, Scott Draeger welcomed Optum Rx president and Chief Operating Officer Jon Mahrt for a recent episo...

Mark as Played

The Seismic Shift in Weight Loss Medicines

March 29, 2023 • 24 mins

One of the most pronounced changes in the pharmacy landscape over the past year has been the rapid emergence of a new class of medications for weight loss known as GLP-1 agonists. Dr. Ana Bhatnagar, Optum Rx Associate Chief Medical Officer, and Dr. Travis Baughn, Optum Rx Vice President of Clinical Solutions join us to discuss what broader use of these promising but expensive medications for weight loss means for both patients a...

Mark as Played

The risky business of alternative funding

November 21, 2022 • 14 mins

Guest: Optum Rx Chief Pharmacy Officer, Michael Einodshofer.
As costly specialty medications continue to enter the market, “alternative funding” is pitched as a way for self-funded employers to make their employees and dependents eligible for “free” medications. Is this a sustainable solution? And what financial, clinical, and even legal risks does this approach entail?

Mark as Played

What you can and can’t expect from biosimilars.

October 26, 2022 • 12 mins

Guest: Sr. Vice President, Optum Rx Clinical and Formulary Services, Savitha Vivian. Long established in Europe, biosimilar alternatives to popular and costly biologic drugs are finally poised to make an impact in the U.S. With biosimilar alternatives to Humira now launching, what does that mean for prescription drug spending?

Mark as Played

What’s happening in Specialty Pharmacy?

September 14, 2022 • 15 mins

Guest: Optum Rx Chief Pharmacy Officer, Michael Einodshofer.
Specialty medications continue to be the single largest driver of prescription drug spending. What separates specialty from traditional pharmacy and what specifics steps can be taken to mitigate rising specialty spend? What do new advances such as gene therapies mean for future specialty costs?

Mark as Played

Popular Podcasts

Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

Death, Sex & Money

Anna Sale explores the big questions and hard choices that are often left out of polite conversation.

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Crime Junkie

If you can never get enough true crime... Congratulations, you’ve found your people.

Start Here

A straightforward look at the day's top news in 20 minutes. Powered by ABC News. Hosted by Brad Mielke.

Advertise With Us

Pharmacy Insights Podcast

Episodes

.css-14f5ked{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:2;overflow:hidden;}The Year Ahead in Pharmacy: What to Expect and What's to Come

.css-r6mb8g{margin:0;word-break:break-word;display:-webkit-box;-webkit-box-orient:vertical;box-orient:vertical;-webkit-line-clamp:1;overflow:hidden;}Preparing For the Gene Therapy Era

Making the Invisible Visible: Why Health Equity Matters

The biosimilar wave has arrived. Now what?

How Choice and Transparency are Changing the PBM Industry

The Seismic Shift in Weight Loss Medicines

The risky business of alternative funding

What you can and can’t expect from biosimilars.

What’s happening in Specialty Pharmacy?

Popular Podcasts

The Year Ahead in Pharmacy: What to Expect and What's to Come

Preparing For the Gene Therapy Era